Curated News
By: NewsRamp Editorial Staff
June 18, 2025
HeartBeam Strengthens Cardiac Care Innovation with New Patents
TLDR
- HeartBeam Inc. secures a competitive edge with two new U.S. patents, enhancing its remote cardiac diagnostics technology and expanding its intellectual property portfolio.
- HeartBeam's 3D ECG device and rhythm analysis algorithm utilize chest and finger electrodes for high-fidelity signal collection and arrhythmia identification, currently under FDA review.
- HeartBeam's innovative cardiac care technology enables early detection of heart conditions outside medical facilities, improving patient outcomes and accessibility to healthcare.
- Discover how HeartBeam is revolutionizing cardiac care with its cable-free 3D ECG device and AI-enhanced diagnostic accuracy, backed by 20 issued patents.
Impact - Why it Matters
This news is significant as it highlights HeartBeam's advancements in remote cardiac diagnostics, offering patients and physicians a portable, efficient solution for monitoring heart health outside traditional medical settings. The integration of AI and the expansion of their patent portfolio could revolutionize how cardiac conditions are diagnosed and managed, making timely and accurate heart care more accessible to people everywhere.
Summary
HeartBeam Inc. (NASDAQ: BEAT), a pioneering medical technology company, has recently bolstered its intellectual property portfolio with the issuance of two new U.S. patents. These patents cover the innovative technologies behind HeartBeam's compact, cable-free 3D ECG device and its advanced rhythm analysis algorithm. The device, designed for on-demand symptom recording and 12-lead ECG synthesis, utilizes chest and finger electrodes to capture high-fidelity signals in three dimensions, offering a groundbreaking approach to remote cardiac diagnostics. Currently under FDA review, the software supporting this device is backed by data from the VALID-ECG pivotal study, promising a new era in cardiac care outside traditional medical facilities.
With a total of 20 issued patents and 34 additional filings, HeartBeam is at the forefront of digital cardiac care innovation. The company's future plans include integrating AI capabilities to further enhance diagnostic accuracy. This development not only signifies a leap forward in cardiac health management but also underscores HeartBeam's commitment to transforming cardiac care by providing powerful insights wherever the patient may be. For more details, visit the full press release at https://ibn.fm/iJ35f.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, HeartBeam Strengthens Cardiac Care Innovation with New Patents
